Is IntelGenx Technologies Corp. (IGXT) a Buy, Sell, or Hold?
OTC : IGXT
IntelGenx Technologies Corp.
$0.17 USD
$0 (0.0%)
- Volume
- 37.23K
- Average Volume
- 17.56K
- Market Capitalization
- $29.69M
- P/E Ratio
- -2.99
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.17
- Year Low
- $0.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.41
Company Overview
OTC
Tommy Kenny
Biotechnology
Healthcare
IGXT
48
CA
USD
Liquidity Metrics
-1.27
0.41
0.40
0.27
0.00
Sales & Valuation
$1.04M
28.58
-2.42
-4.43
-0.04
Profitability
-$0.0568
-$9.93M
-955.44%
-955.44%
126.70%
-119.86%
P/E Metrics
-2.99
-0.09
-0.09
Analyst Price Target & Rating
0/5
2 Analysts
%
Financial Health Scores
-23.81
4/9
-$14.44M
$6.55M
$21.91M
-$8.93M
Key Metrics (TTM)
$42.91M
41.30
-5.69
0.41
126.70%
-291.67%
-33.43%
-22.58%
-268 days
Company Executives
| Name | Title |
|---|---|
| Stephen Kilmer | Investor Relations Officer |
| Tommy Kenny | Senior Vice President & General Counsel |
| Zenoz Nina Pourhassan | Vice President of Quality Operations of Subsidiary |
| Karen Kalayajian | Vice President of Finance & Administration |
| Nadine Paiement | Vice-Chair of Scientific Advisory Board and Vice President of Research & Development - IntelGenx Corp |
Poll Results
No votes yet today — be the first to share your view!
About IntelGenx Technologies Corp. (OTC:IGXT) Stock
IntelGenx Technologies Corp. operates as a specialized drug delivery firm, concentrating on the creation and production of innovative oral thin film products for the pharmaceutical industry. Their current portfolio features several oral film formulations: INT0008/2008, a Rizatriptan product addressing migraine headaches; INT0046/2018, intended for adult applications; INT0007/2006, developed for the treatment of erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, aimed at combating opioid addiction; INT0010/2006, designed to alleviate neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film for schizophrenia or bipolar 1 disorder; and INT0048/2020, catering to animal health. Furthermore, IntelGenx is a ... dvancing additional projects in its development pipeline, specifically INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established various agreements, including licensing, development, and supply arrangements with Tilray, Inc., alongside a development partnership with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Frequently Asked Questions
-
What is the current IntelGenx Technologies Corp. (IGXT) stock price?
-
IntelGenx Technologies Corp.(OTC:IGXT) stock price is $0.17 in the last trading session. During the trading session, IGXT stock reached the peak price of $0.17 while $0.1593 was the lowest point it dropped to. The percentage change in IGXT stock occurred in the recent session was 0.0% while the dollar amount for the price change in IGXT stock was $0.
-
IGXT's industry and sector of operation?
-
The OTC listed IGXT is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IGXT?
-
Stephen Kilmer | Investor Relations Officer
Tommy Kenny | Senior Vice President & General Counsel
Zenoz Nina Pourhassan | Vice President of Quality Operations of Subsidiary
Karen Kalayajian | Vice President of Finance & Administration
Nadine Paiement | Vice-Chair of Scientific Advisory Board and Vice President of Research & Development - IntelGenx Corp -
How many employees does IGXT have?
-
Number of IGXT employees currently stands at 48. IGXT operates from 6420 Abrams, Montreal, QC H4S 1Y2, CA.
-
Link for IGXT official website?
-
Official Website of IGXT is: https://www.intelgenx.com
-
How do I contact IGXT?
-
IGXT could be contacted at phone #514 331 7440 and can also be accessed through its website. IGXT operates from 6420 Abrams, Montreal, QC H4S 1Y2, CA.
-
How many shares of IGXT are traded daily?
-
The average number of IGXT shares traded daily for last 3 months was 17.56K.
-
What is the market cap of IGXT currently?
-
The market value of IGXT currently stands at $29.69M with its latest stock price at $0.17